Synergism of Telmisartan and Amlodipine on Blood Pressure Reduction and Cardiorenal Protection in Hypertensive Rats-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Synergism of Telmisartan and Amlodipine on Blood Pressure Reduction and Cardiorenal Protection in Hypertensive Rats

Published:2011-03 Issue:3 Volume:57 Page:308-316
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:Journal of Cardiovascular Pharmacology

Author:

Liu Wei,Wang Wei,Song Shu-Wei,Gu Xiao-Fei,Ma Xiu-Juan,Su Feng-Yun,Zhang Hao,Liu Ai-Jun,Su Ding-Feng

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference31 articles.

1. Hypertensive Therapy: Part II

2. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureThe JNC 7 Report

3. Additive beneficial effects of amlodipine and atorvastatin in reversing advanced cardiac hypertrophy in elderly spontaneously hypertensive rats

4. EFFECT OF CALCIUM CHANNEL BLOCKADE ON ADRENERGICALLY INDUCED RENAL VASOCONSTRICTION IN RAT MODELS OF RENAL IMPAIRMENT

5. Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergism of amlodipine and telmisartan or candesartan on blood pressure reduction by using SynergyFinder 3.0 and probability sum test in vivo;Pharmacology Research & Perspectives;2023-02-22

2. Release Behavior of Telmisartan/Amlodipine Combination Drug According to Polymer Type;Macromolecular Research;2021-03

3. Synergism of amlodipine and candesartan on blood pressure reduction and organ protection in hypertensive rats;Clinical and Experimental Pharmacology and Physiology;2018-01-16

4. Renal denervation decreases blood pressure and renal tyrosine hydroxylase but does not augment the effect of hypotensive drugs;Clinical and Experimental Hypertension;2017-04-03

5. Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal disease;Pharmacology & Therapeutics;2016-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3